PCSK9 Inhibitors (e.g., Evolocumab)
Treatment used for 1 condition
Total Trials
50
Total Participants
70K
Avg Effectiveness
78%
Avg Safety Score
65%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.